NSCLC is usually treated through surgery, radiation therapy, chemotherapy, targeted therapy and immunotherapy. Treatment options vary depending on the type and stage of the cancer. Surgery is the main treatment for stage I to IIIA NSCLC, while stage IIIB to IV patients are treated with radiation ...
189]. Recent studies have shown that CAR-T cell-derived exosomes as a cell-free therapy not only retain most of the functions of CAR-T cells but also have greater therapeutic efficiency, higher controllability, lower toxicity, and
Nucleic acid-based treatments, particularly messenger RNA (mRNA), have played a pivotal role in recent advances in RNA-based vaccination, protein replacement therapy, gene editing, and cancer immunotherapy [2]. Recently, two mRNA vaccines targeting severe acute respiratory coronavirus type 2 (SARS-...
NSCLC is usually treated through surgery, radiation therapy, chemotherapy, targeted therapy and immunotherapy. Treatment options vary depending on the type and stage of the cancer. Surgery is the main treatment for stage I to IIIA NSCLC, while stage IIIB to IV patients are treated with radiation ...
Exosome Delivered Anticancer Drugs Across the Blood-Brain Barrier for Brain Cancer Therapy in Danio Rerio. Pharm. Res. 2015, 32, 2003–2014. [CrossRef] [PubMed] 29. Wood, M.J.; O'Loughlin, A.J.; Lakhal, S. Exosomes and the blood–brain barrier: Implications for neurological diseases....
In addition, there is ample evidence of the involvement of oxidative stress in the pathogenesis of both Down's syndrome and AD [46]. Therefore, RNA aptamers specific for membrane Aβ could potentially serve both in AD treatment and as dementia-preventive therapy for children and young adults ...